Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance at Dec. 31, 2022	$ 663,332	$ 36	$ 435,665	$ (9,644)	$ 237,275
Beginning balance (in shares) at Dec. 31, 2022		35,611,219
Stock-based compensation	5,807		5,807
Common stock issued upon exercises of options	578		578
Common stock issued upon exercises of options (in shares)		149,408
Currency translation adjustment	(2,006)			(2,006)
Unrealized gain (loss) on available-for-sale securities	102			102
Net income (loss)	(15,551)				(15,551)
Ending balance at Mar. 31, 2023	652,262	$ 36	442,050	(11,548)	221,724
Ending balance (in shares) at Mar. 31, 2023		35,760,627
Beginning balance at Dec. 31, 2022	663,332	$ 36	435,665	(9,644)	237,275
Beginning balance (in shares) at Dec. 31, 2022		35,611,219
Net income (loss)	(49,851)
Ending balance at Jun. 30, 2023	623,526	$ 36	449,232	(13,166)	187,424
Ending balance (in shares) at Jun. 30, 2023		35,781,919
Beginning balance at Mar. 31, 2023	652,262	$ 36	442,050	(11,548)	221,724
Beginning balance (in shares) at Mar. 31, 2023		35,760,627
Stock-based compensation	6,964		6,964
Common stock issued upon exercises of options	218		218
Common stock issued upon exercises of options (in shares)		21,292
Currency translation adjustment	104			104
Unrealized gain (loss) on available-for-sale securities	(1,722)			(1,722)
Net income (loss)	(34,300)				(34,300)
Ending balance at Jun. 30, 2023	623,526	$ 36	449,232	(13,166)	187,424
Ending balance (in shares) at Jun. 30, 2023		35,781,919
Beginning balance at Dec. 31, 2023	575,228	$ 36	463,799	(13,240)	124,633
Beginning balance (in shares) at Dec. 31, 2023		35,838,080
Stock-based compensation	7,263		7,263
Common stock issued upon exercises of options	22		22
Common stock issued upon exercises of options (in shares)		5,676
Currency translation adjustment	(2,265)			(2,265)
Unrealized gain (loss) on available-for-sale securities	(832)			(832)
Net income (loss)	(38,216)				(38,216)
Ending balance at Mar. 31, 2024	541,200	$ 36	471,084	(16,337)	86,417
Ending balance (in shares) at Mar. 31, 2024		35,843,756
Beginning balance at Dec. 31, 2023	$ 575,228	$ 36	463,799	(13,240)	124,633
Beginning balance (in shares) at Dec. 31, 2023		35,838,080
Common stock issued upon exercises of options (in shares)	405,559
Net income (loss)	$ (45,344)
Ending balance at Jun. 30, 2024	663,868	$ 37	601,102	(16,560)	79,289
Ending balance (in shares) at Jun. 30, 2024		36,519,945
Beginning balance at Mar. 31, 2024	541,200	$ 36	471,084	(16,337)	86,417
Beginning balance (in shares) at Mar. 31, 2024		35,843,756
Stock-based compensation	8,062		8,062
Common stock issued upon exercises of options, ESPP purchases, and restricted stock unit releases (in shares)		433,332
Common stock issued upon exercises of options, ESPP purchases, and release of restricted stock units	2,383		2,383
Issuance of common stock and pre-funded warrants, net of offering costs (in shares)		1,142,857
Issuance of common stock and pre-funded warrants, net of offering costs	119,574	$ 1	119,573
Exchange of common stock for pre-funded warrants (in shares)		(900,000)
Currency translation adjustment	(151)			(151)
Unrealized gain (loss) on available-for-sale securities	(72)			(72)
Net income (loss)	(7,128)				(7,128)
Ending balance at Jun. 30, 2024	$ 663,868	$ 37	$ 601,102	$ (16,560)	$ 79,289
Ending balance (in shares) at Jun. 30, 2024		36,519,945